2-methylene-19-nor-vitamin D2 compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C552S653000

Reexamination Certificate

active

10922114

ABSTRACT:
2-Methylene-19-nor-24(S) and 24(R) derivatives of 1α,25-dihydroxyvitamin D2are disclosed. These compounds are characterized by minimal bone calcium mobilization activity and relatively high intestinal calcium transport activity. This results in novel therapeutic agents for the treatment of diseases such as renal osteodystrophy, autoimmune diseases, and osteoporosis. These compounds also exhibit pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as anticancer agents and for use treating skin diseases such as psoriasis

REFERENCES:
patent: 4588716 (1986-05-01), DeLuca et al.
patent: 4666634 (1987-05-01), Miyamoto et al.
patent: 4769181 (1988-09-01), DeLuca et al.
patent: 4973584 (1990-11-01), DeLuca et al.
patent: 5036061 (1991-07-01), DeLuca et al.
patent: 5086191 (1992-02-01), DeLuca et al.
patent: 5536713 (1996-07-01), Deluca et al.
patent: 5843928 (1998-12-01), Deluca et al.
patent: 6440953 (2002-08-01), DeLuca et al.
patent: 6479474 (2002-11-01), DeLuca et al.
patent: 6673782 (2004-01-01), DeLuca et al.
patent: 2004/0053813 (2004-03-01), DeLuca et al.
Ostrem et al., “24- and 26-homo-1,25-dihydroxyvitamin D3: Preferential activity in inducing differentiation of human leukemia cells HL-60in vitro,” Proc. Natl. Acad. Sci. USA, vol. 84, pp. 2610-2614 (1987).
Ostrem et al., “Induction of Monocytic Differentiation of HL-60 Cells by 1,25-Dihydroxyvitamin D Analogs,”J. Biol. Chem., vol. 262, No. 29, pp. 14164-14171 (1987); published by The American Society for Biochemistry and Molecular Biology, Inc.
Perlman et al., “1α,25-Dihydroxy-19-Nor-Vitamin D3, A Novel Vitamin D-Related Compound with Potential Therapeutic Activity,”Tetrahedron Lett., vol. 31, No. 13, pp. 1823-1824 (1990); published by Pergamon Press, Great Britain.
Perlman et al., “Novel Synthesis of 19-Nor-Vitamin D Compounds,”Tetrahedron Lett., vol. 32, No. 52, 7663-7666 (1991); published by Pergamon Press, Great Britain.
Okano et al., “Regulatory Activities of 2β-(3-Hydroxypropoxy)-1α, 25-Dihydroxy-Vitamin D3, a novel Synthetic Vitamin D3Derivative, on Calcium Metabolism,”Biochem. Biophys. Res. Commun., vol. 163, No. 3, 1444-1449 (1989); published by Academic Press, Inc.
Miyamoto et al., “Synthetic Studies of Vitamin D Analogues. XIV. Synthesis and Calcium Regulating Activity of Vitamin D3Analogues Bearing a Hydroxyalkoxy Group at the 2β-Position,”Chem. Pharm. Bull., vol. 41, No. 6, pp. 1111-1113 (1993); published by Pharmaceutical Society of Japan.
Nishii et al., “The Development of Vitamin D3Analogues for the Treatment of Osteoporosis,”Osteoporosis Int. Suppl., vol. 1, 190-193 (1993); published by European Foundation for Osteoporosis.
Posner et al., Stereocontrolled Total Synthesis of Calcitriol Derivatives: 1,25-Dihydryxy-2(4′-hydroxybutyl) vitamin D3Analogs of an osteoporosis Drug,J. Org. Chem., vol. 59, 7855-7861 (1994); published by American Chemical Society.
Posner et al., “2-Fluoroalkyl A-Ring Analogs of 1,25-Dihydroxyvitamin D3Stereocontrolled Total Synthesis via Intramolecular and Intermolecular Diels—Alder Cycloadditions. Preliminary Biological Testing,”J. Org. Chem., vol. 60, 4617-4628 (1995); published by American Chemical Society.
Lythgoe et al., “Calciferol and its Relatives. Part 22. A direct total Synthesis of Vitamin D2and Vitamin D3, ”J. Chem. Soc. Perkin Trans. I, 590-595 (1978).
Lythgoe, “Synthetic Approaches to Vitamin D and its Relatives,”Chem. Soc. Rev., vol. 9, 449-475 (1983).
Toh et al., “Studies on a Convergent Route to Side-Chain Analogues of Vitamin D: 25-Hydroxy-23-oxavitamin D3,”J. Org. Chem., vol. 48, 1414-1417 (1983); published by American Chemical Society.
Baggiolini et al., “Stereocontrolled Total Synthesis of 1α,25-Dihydroxyergocalciferol,”J. Org. Chem., vol. 51, 3098-3108 (1986); published by American Chemical Society.
Sardina et al., “Studies on the Synthesis of Side-Chain Hydroxylated Metabolites of Vitamin D. 2. Stereocontrolled Synthesis of 25-Hydroxyvitamin D2”J. Org. Chem., vol. 51, 1264-1269 (1986); published by American Chemical Society.
Mascareñas et al., “Studies on the Synthesis of Side-Chain Hydroxylated Metabolites of Vitamin D. 3. Synthesis of 25-Ketovitamin D3and 25-Hydroxyvitamin D3,”J. Org. Chem., vol. 51, pp. 1269-1272 (1986).
Mincione et al., “Improved Conversion of Vitamin D2into the Windaus Ketone and its Regioselective Hydroxylation via Organoboranes at C26,”Synth. Commun., vol. 19, 723-735 (1989); published by Marcel Dekker, Inc.
Peterson et al., Studies of the Ketone Obtained from the Ozonolysis of Vitamin D. Molecular Mechanics Calculations for It and Related Hydrindanones,:J. Org. Chem., vol. 51, 1948-1954 (1986); published by American Chemical Society.
Sicinski et al., “New 1α,25-Dihydroxy-19-norvitamin D3Compounds of High Biological Activity: Synthesis and Biological Evaluation of 2-Hydroxymethyl, 2-Methy., and 2-Methylene Analogues,”J. Med. Chem., vol. 41, 4662-4674 (1998); published by American Chemical Society.
Kutner et al., “Novel Convergent Synthesis of Side-Chain-Modified Analogues of 1α,25-Dihydroxycholecalciferol and 1α,25-Dihydroxyergocalciferol,”J. Org. Chem., vol. 53, 3450-3457 (1988); published by American Chemical Society.
Dame et al., “Monoclonal Antibodies to the Porcine Intestinal Receptor for 1,25-Dihydroxyvitamin D3: Interaction with Distinct Receptor Domains,”Biochemistry, vol. 25, pp. 4523-4534 (1986); published American Chemical Society.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2-methylene-19-nor-vitamin D2 compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-methylene-19-nor-vitamin D2 compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-methylene-19-nor-vitamin D2 compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3853565

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.